Michael R Cook

4PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Other biomedical and clinical sciences not elsewhere classifiedPredictive and prognostic markersImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 19, 2022
Toxicity and efficacy of CAR T-cell therapy in primary and secondary CNS lymphoma: a meta-analysis of 128 patients.

Michael R Cook, C Scott Dorris, Kepher H Makambi

|Sep 23, 2022
Correction: Zhang et al. Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis. Cancers 2021, 13, 6109.

Dongyu Zhang, Neil J Shah, Michael Cook

|Jul 18, 2022
The spectrum of genetic mutations in myelodysplastic syndrome: Should we update prognostication?

Michael R Cook, Judith E Karp, Catherine Lai

|Dec 10, 2021
Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis.

Dongyu Zhang, Neil J Shah, Michael Cook

Pageof 1

Frequent Collaborators

2 joint publications

Neil J Shah

2 joint publications

Arnold L Potosky

2 joint publications

Michael B Atkins

1 joint publications

Anas Belouali